TRITACE 10 clinical trials

A randomized, open-label, single dose, cross-over bioavailability study evaluating the drug-drug interaction between Tritace 10, 10 mg, tablets and Tertensif SR 1.5 mg prolonged-release film-coated tablets when co-administered versus the administration of each product alone in two cohorts of healthy volunteers under fasting conditions. Sponsor's Study No.: RAM-IND-DDI-05-23

This study looks at how two common blood pressure medicines, Tritace 10 and Tertensif SR, act in the body when taken together compared to taking them alone. It's for healthy volunteers to see if one medicine changes how the other works.